Characterization of organogel as a novel oral controlled release formulation for lipophilic compounds
Kazunori Iwanaga(Osaka University of Pharmaceutical Sciences), Masawo Kakemi(Osaka University of Pharmaceutical Sciences), Makoto Miyazaki(Chiba Cancer Center), Toru Sumizawa(Osaka University of Pharmaceutical Sciences)
Cited by 95
Related Papers
Loss of stearoyl–CoA desaturase-1 function protects mice against adiposity
|Proceedings of the National Academy of Sciences|2002|1.1k
Role for Stearoyl-CoA Desaturase-1 in Leptin-Mediated Weight Loss
|Science|2002|833
The Biosynthesis of Hepatic Cholesterol Esters and Triglycerides Is Impaired in Mice with a Disruption of the Gene for Stearoyl-CoA Desaturase 1
|Journal of Biological Chemistry|2000|453
Hepatic Stearoyl-CoA Desaturase-1 Deficiency Protects Mice from Carbohydrate-Induced Adiposity and Hepatic Steatosis
|Cell Metabolism|2007|433
Stearoyl-CoA desaturase 1 deficiency increases fatty acid oxidation by activating AMP-activated protein kinase in liver
|Proceedings of the National Academy of Sciences|2004|404